Yaşa Gül Mutlu

7PUBLICATIONS
66CO-AUTHORS
Regenerative medicine (incl. stem cells)PharmacogenomicsRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 27, 2025
When high dose methotrexate stops working, a successful bridge to transplant with TEDDI-R in a case of secondary CNS lymphoma.

Süreyya Yiğit Kaya, Elif Melek, Yaşa Gül Mutlu

|Feb 07, 2025
Original vs. Generic Plerixafor for the Mobilization of Stem Cells in Multiple Myeloma Patients.

Süreyya Yiğit Kaya, Yaşa Gül Mutlu, Orhan Kemal Yücel

|Apr 26, 2023
Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient.

Süreyya Yiğit Kaya, Sebnem Bektas, Abdullah Emre Askin

|Apr 03, 2023
Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation: Intensive Care Outcome in Hematopoietic Stem Cell Transplantation.

Yaşa Gül Mutlu, Berrin Balik Aydin, Cem Erdogan

|Jul 29, 2022
To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission.

Omur Gokmen Sevindik, Mahmut Mergen, Sena Mergen

|Sep 15, 2021
Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

Sinem Civriz Bozdağ, Güldane Cengiz Seval, İpek Yönal Hindilerden

Pageof 2

Frequent Collaborators

6 joint publications

Ömür Gökmen Sevindik

4 joint publications

Berrin Balık Aydın

3 joint publications

Süreyya Yiğit Kaya

3 joint publications

Senem Maral